Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitorsRenguo Guan, Rongping Guo, Jie Mei et al.|International Journal of Surgery|2024Cited by 36
Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trialsYangxun Pan, Zhongguo Zhou, Li Xu et al.|Frontiers in Bioscience-Landmark|2021Cited by 19
Stereotactic body radiotherapy vs radiofrequency ablation in the treatment of hepatocellular carcinoma: a meta-analysisYangxun Pan, Yaojun Zhang, Long Qian et al.|Research Square|2019Cited by 2